Clinical Trial Update: Continuous Glucose Monitoring Evaluation of Exenatide Twice Daily Versus Insulin Glargine [NA]

View source ↗

Summary

A completed clinical trial evaluated continuous glucose monitoring outcomes for exenatide given twice daily versus insulin glargine in type 2 diabetes. The stud…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• BYETTA (Exenatide)
• Lantus (insulin glargine)

Snippet

Sponsor: HealthPartners Institute | Conditions: Type 2 Diabetes | NA | Status: COMPLETED | Results posted: 2017-05-23